{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T21:53:38Z","timestamp":1767909218703,"version":"3.49.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T00:00:00Z","timestamp":1556150400000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DA016017"],"award-info":[{"award-number":["R01 DA016017"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19 AI082630"],"award-info":[{"award-number":["U19 AI082630"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K24 AA022586"],"award-info":[{"award-number":["K24 AA022586"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4,1]]},"DOI":"10.1093\/ofid\/ofz125","type":"journal-article","created":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T13:04:43Z","timestamp":1556197483000},"source":"Crossref","is-referenced-by-count":8,"title":["Role of HCV Viremia in Corroborated HCV Transmission Events Within Young Adult Injecting Partnerships"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2697-8264","authenticated-orcid":false,"given":"Judith A","family":"Hahn","sequence":"first","affiliation":[{"name":"Department of Medicine, University of California, San Francisco, San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien C","family":"Tully","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L","family":"Evans","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan D","family":"Morris","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alya","family":"Briceno","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J","family":"Bean","sequence":"additional","affiliation":[{"name":"Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd M","family":"Allen","sequence":"additional","affiliation":[{"name":"Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Page","sequence":"additional","affiliation":[{"name":"University of New Mexico, Albuquerque, New Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,4,25]]},"reference":[{"key":"2019042513031493400_CIT0001","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1093\/cid\/cit300","article-title":"Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention","volume":"57","author":"Page","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2019042513031493400_CIT0002","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/aje\/kwn237","article-title":"Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place","volume":"168","author":"Hagan","year":"2008","journal-title":"Am J Epidemiol"},{"key":"2019042513031493400_CIT0003","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11904-014-0248-2","article-title":"Novel interventions to prevent HIV and HCV among persons who inject drugs","volume":"12","author":"Coffin","year":"2015","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2019042513031493400_CIT0004","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/cid\/ciw869","article-title":"Geographic differences in temporal incidence trends of hepatitis C virus infection among people who inject drugs: the InC3 collaboration","volume":"64","author":"Morris","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2019042513031493400_CIT0005","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/cid\/ciu643","article-title":"Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006\u20132012","volume":"59","author":"Suryaprasad","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2019042513031493400_CIT0006","first-page":"453","article-title":"Increases in hepatitis C virus infection related to injection drug use among persons aged <\/=30 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006\u20132012","volume":"64","author":"Zibbell","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2019042513031493400_CIT0007","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugpo.2013.07.001","article-title":"Interventions to prevent HIV and hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness","volume":"25","author":"MacArthur","year":"2014","journal-title":"Int J Drug Policy"},{"key":"2019042513031493400_CIT0008","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1001\/jamainternmed.2014.5416","article-title":"Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users","volume":"174","author":"Tsui","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2019042513031493400_CIT0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinf.2013.08.019","article-title":"Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents","volume":"68","author":"Conteduca","year":"2014","journal-title":"J Infect"},{"key":"2019042513031493400_CIT0010","doi-asserted-by":"crossref","first-page":"851","DOI":"10.2174\/1389450116666150825111314","article-title":"Direct-acting antivirals for hepatitis C virus (HCV): the progress continues","volume":"18","author":"Feld","year":"2017","journal-title":"Curr Drug Targets"},{"key":"2019042513031493400_CIT0011","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/ajg.2014.66","article-title":"The rapid evolution of treatment strategies for hepatitis C","volume":"109","author":"Muir","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"2019042513031493400_CIT0012","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa1512610","article-title":"Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection","volume":"373","author":"Feld","year":"2015","journal-title":"N Engl J Med"},{"key":"2019042513031493400_CIT0013","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jhep.2016.02.007","article-title":"Prioritization of HCV treatment in the direct-acting antiviral era: an economic evaluation","volume":"65","author":"Martin","year":"2016","journal-title":"J Hepatol"},{"key":"2019042513031493400_CIT0014","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S2468-1253(16)30075-9","article-title":"Hepatitis C treatment as prevention: evidence, feasibility, and challenges","volume":"1","author":"Hajarizadeh","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2019042513031493400_CIT0015","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nm.3183","article-title":"Current progress in development of hepatitis C virus vaccines","volume":"19","author":"Liang","year":"2013","journal-title":"Nat Med"},{"key":"2019042513031493400_CIT0016","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.coviro.2017.03.014","article-title":"Designing an HCV vaccine: a unique convergence of prevention and therapy?","volume":"23","author":"Walker","year":"2017","journal-title":"Curr Opin Virol"},{"key":"2019042513031493400_CIT0017","article-title":"Model-based analysis of patient immunity profiles indicates that vaccination could reduce hepatitis C transmission via syringe sharing","author":"Major","year":"2018; 10:4496","journal-title":"Sci Transl Med"},{"key":"2019042513031493400_CIT0018","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejogrb.2015.09.009","article-title":"Risk factors for vertical transmission of hepatitis C virus: a single center experience with 710 HCV-infected mothers","volume":"194","author":"Garcia-Tejedor","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2019042513031493400_CIT0019","doi-asserted-by":"crossref","first-page":"e0122232","DOI":"10.1371\/journal.pone.0122232","article-title":"Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study","volume":"10","author":"Hajarizadeh","year":"2015","journal-title":"PLoS One"},{"key":"2019042513031493400_CIT0020","doi-asserted-by":"crossref","first-page":"e109282","DOI":"10.1371\/journal.pone.0109282","article-title":"Intimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CA","volume":"9","author":"Morris","year":"2014","journal-title":"PLoS One"},{"key":"2019042513031493400_CIT0021","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1086\/605947","article-title":"Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection","volume":"200","author":"Page","year":"2009","journal-title":"J Infect Dis"},{"key":"2019042513031493400_CIT0022","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1186\/s12879-017-2773-2","article-title":"Diagnostic accuracy of tests to detect hepatitis C antibody: a meta-analysis and review of the literature","volume":"17","author":"Tang","year":"2017","journal-title":"BMC Infect Dis"},{"key":"2019042513031493400_CIT0023","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1128\/JCM.44.3.729-737.2006","article-title":"Comparison of conventional PCR with real-time PCR and branched DNA-based assays for hepatitis C virus RNA quantification and clinical significance for genotypes 1 to 5","volume":"44","author":"Sarrazin","year":"2006","journal-title":"J Clin Microbiol"},{"key":"2019042513031493400_CIT0024","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1128\/JCM.00755-08","article-title":"Differences between two real-time PCR-based hepatitis C virus (HCV) assays (RealTime HCV and Cobas AmpliPrep\/Cobas TaqMan) and one signal amplification assay (Versant HCV RNA 3.0) for RNA detection and quantification","volume":"46","author":"Vermehren","year":"2008","journal-title":"J Clin Microbiol"},{"key":"2019042513031493400_CIT0025","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1128\/JCM.02366-06","article-title":"Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C\/E1 and 5\u2019 untranslated region sequences","volume":"45","author":"Murphy","year":"2007","journal-title":"J Clin Microbiol"},{"key":"2019042513031493400_CIT0026","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1186\/1471-2164-13-475","article-title":"De novo assembly of highly diverse viral populations","volume":"13","author":"Yang","year":"2012","journal-title":"BMC Genomics"},{"key":"2019042513031493400_CIT0027","doi-asserted-by":"crossref","first-page":"e1002529","DOI":"10.1371\/journal.ppat.1002529","article-title":"Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection","volume":"8","author":"Henn","year":"2012","journal-title":"PLoS Pathog"},{"key":"2019042513031493400_CIT0028","doi-asserted-by":"crossref","first-page":"e1005619","DOI":"10.1371\/journal.ppat.1005619","article-title":"Differences in the selection bottleneck between modes of sexual transmission influence the genetic composition of the HIV-1 founder virus","volume":"12","author":"Tully","year":"2016","journal-title":"PLoS Pathog"},{"key":"2019042513031493400_CIT0031","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/QAI.0000000000001158","article-title":"Treatment as prevention: characterization of partner infections in the HIV prevention trials network 052 trial","volume":"74","author":"Eshleman","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2019042513031493400_CIT0032","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1086\/429411","article-title":"Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda","volume":"191","author":"Wawer","year":"2005","journal-title":"J Infect Dis"},{"key":"2019042513031493400_CIT0033","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3389\/fmicb.2018.01326","article-title":"Correlation between anti-gp41 antibodies and virus infectivity decay during primary HIV-1 infection","volume":"9","author":"Vaidya","year":"2018","journal-title":"Front Microbiol"},{"key":"2019042513031493400_CIT0034","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/QCO.0000000000000216","article-title":"Hepatitis C virus treatment as prevention in people who inject drugs: testing the evidence","volume":"28","author":"Hickman","year":"2015","journal-title":"Curr Opin Infect Dis"},{"key":"2019042513031493400_CIT0035","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12916-015-0440-2","article-title":"The role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatments","volume":"13","author":"Scott","year":"2015","journal-title":"BMC Med"},{"key":"2019042513031493400_CIT0036","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/infdis\/jis213","article-title":"The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study design","volume":"205","author":"Vickerman","year":"2012","journal-title":"J Infect Dis"},{"key":"2019042513031493400_CIT0037","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/jmv.24010","article-title":"Dynamics of HCV RNA levels during acute hepatitis C virus infection","volume":"86","author":"Hajarizadeh","year":"2014","journal-title":"J Med Virol"},{"key":"2019042513031493400_CIT0038","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.jhep.2016.02.031","article-title":"Transmission of hepatitis C virus infection among younger and older people who inject drugs in Vancouver, Canada","volume":"64","author":"Jacka","year":"2016","journal-title":"J Hepatol"},{"key":"2019042513031493400_CIT0039","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.drugalcdep.2015.04.005","article-title":"Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among street-involved youth in Vancouver, Canada","volume":"152","author":"Cunningham","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"2019042513031493400_CIT0040","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/hep.27310","article-title":"Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, Canada","volume":"60","author":"Jacka","year":"2014","journal-title":"Hepatology"},{"key":"2019042513031493400_CIT0041","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/jvh.12616","article-title":"Phylogenetic analysis of full-length, early infection, hepatitis C virus genomes among people with intravenous drug use: the InC3 study","volume":"24","author":"Rodrigo","year":"2017","journal-title":"J Viral Hepat"},{"key":"2019042513031493400_CIT0042","doi-asserted-by":"crossref","first-page":"e47335","DOI":"10.1371\/journal.pone.0047335","article-title":"Hepatitis C virus phylogenetic clustering is associated with the social-injecting network in a cohort of people who inject drugs","volume":"7","author":"Sacks-Davis","year":"2012","journal-title":"PLoS One"},{"key":"2019042513031493400_CIT0043","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.drugpo.2016.11.016","article-title":"Social mixing and correlates of injection frequency among opioid use partnerships","volume":"41","author":"Rowe","year":"2017","journal-title":"Int J Drug Policy"},{"key":"2019042513031493400_CIT0044","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0140-6736(02)08435-0","article-title":"Protection against persistence of hepatitis C","volume":"359","author":"Mehta","year":"2002","journal-title":"Lancet"},{"key":"2019042513031493400_CIT0045","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/cid\/cis921","article-title":"Frequent longitudinal sampling of hepatitis C virus infection in injection drug users reveals intermittently detectable viremia and reinfection","volume":"56","author":"Page","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2019042513031493400_CIT0046","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.drugalcdep.2014.06.028","article-title":"Concordance of risk behavior reporting within HCV serodiscordant injecting partnerships of young injection drug users in San Francisco, CA","volume":"142","author":"Evans","year":"2014","journal-title":"Drug Alcohol Depend"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/6\/4\/ofz125\/28529715\/ofz125.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T13:04:52Z","timestamp":1556197492000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofz125\/5479956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,1]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,4,25]]},"published-print":{"date-parts":[[2019,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofz125","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,4]]},"published":{"date-parts":[[2019,4,1]]}}}